Biotech Values

[drbio45]

Dendreon gave absolutely no data. They are keeping it under wraps for the AUA meeting.

Companies usually give some data, even though they are going to give more detail at an upcoming meeting. Everyone says if they didn't meet the endpoint they will go to jail.

I haven't seen the CEO or anyone else at GTC Biotech go to jail even though they met the endpoint, until they didn't. It was just a different interpretation of the data.

That could be what we have here. What is adding to my skepticism is the fact that they aren't filing the NDA until the 4th quarter. This is an open NDA, so all of the modules are already complete. All they have to do is insert the data from this trial. The rest of the NDA is already done. When companies delay the NDA it is usually because the longer they delay it, the longer the stock can stay afloat, because the longer the rejection is delayed.

I didn't have a position either way, I hope the data is great but I have a feeling that it isn't overwhelming even if it met the endpoint.